Management Team

 Dr. Richard B. Stein, President and Member of the Board

Richard Stein

Dr. Stein’s has contributed to the development and commercialization of numerous medical devices. His latest contribution is the Walkaide ™, a miniature neuroprosthetic device for correcting foot drop, commercialized by Biomotion and licensed to Hanger Orthopedic . He was also a key contributor to the development and commercialization of the C-Leg for below the knee amputees, which is now sold by Ottobock. He is considered one of the world’s foremost experts in neuralprosthetic research. He founded the Division of Neuroscience, now the Centre for Neuroscience , at the University of Alberta. This Centre is ranked among the leading Centres of its kind. He has published over over 230 scientific journal articles. His wealth of clinical, administrative and commercialization expertise will be an invaluable contribution to the management and daily functions of the Prev Biotech team.


Henry Kay, Interim CEO

Henry Kay

Mr. Kay brings over 35 years of medical devince and pharmaceutical industry experience to Prev Biotech’s Board of Directors. Henry recently retired as Group Vice President of New Market Development/Strategic Planning, Endosurgery at Boston Scientific Corporation , where he was responsible for identification and assessment of investment and acquisition opportunities. Prior to Boston Scientific, Henry was in the UK as Senior VP, Sales and Marketing for Allergan Europe. Henry also held senior positions in Schering-Plough and American Home Products. In addition, Henry sits on the boards of several startups health care companies and is a mentor with the Venture Mentoring Services of MIT.


Dr. Vivian Mushahwar, Vice President, Chief Scientific Scientist and Acting Chair of the Board


Dr. Mushahwar is an established bioengineer and a world-leading pressure ulcer and neuralprosthetic researcher. She is the current Leader of Project SMART , a multi-disciplinary research network of over 16 research groups and 6 research institutions across North America, and the Scientific Director of the Centre for Neural Interfaces and Rehabilitation Neuroscience at the University of Alberta. Her leadership and scientific excellence have been recongnized through numerous national and international awards including the Distinguished Women in Neural Engineering, Women of Vision, and Alberta Heritage Foundation for Medical Research (AHFMR) Senior Scholar awards. She is actively involved in a scientific research capacity in health-related organizations and patient groups and is frequently invited as a guest lecturer and scientific advisor.